메뉴 건너뛰기




Volumn 24, Issue 3, 2003, Pages 180-181

Neuroprotective effects mediated by dopamine receptor agonists against malonate-induced lesion in the rat striatum

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MALONIC ACID; QUINPIROLE;

EID: 0142217552     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-003-0119-x     Document Type: Article
Times cited : (8)

References (8)
  • 1
    • 0027198567 scopus 로고
    • Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum
    • Greene J, Porter RHP, Eller R, Greenamyre J (1993) Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J Neurochem 61:1151-1154
    • (1993) J. Neurochem. , vol.61 , pp. 1151-1154
    • Greene, J.1    Porter, R.H.P.2    Eller, R.3    Greenamyre, J.4
  • 2
    • 0029933450 scopus 로고    scopus 로고
    • Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections
    • Hastings TG, Lewis DA, Zigmond MJ (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A 93:1956-1961
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 1956-1961
    • Hastings, T.G.1    Lewis, D.A.2    Zigmond, M.J.3
  • 3
    • 0032840882 scopus 로고    scopus 로고
    • Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation
    • Ferger B, Eberhardt O, Teismann P, Groote C de, Schulz JB (1999) Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation. J Neurochem 73:1329-1332
    • (1999) J. Neurochem. , vol.73 , pp. 1329-1332
    • Ferger, B.1    Eberhardt, O.2    Teismann, P.3    de Groote, C.4    Schulz, J.B.5
  • 4
    • 0002326977 scopus 로고
    • Potential neuroprotective therapy in Parkinson's disease
    • Mizuno BE, Mori H, Kondo T (1994) Potential neuroprotective therapy in Parkinson's disease. CNS Drugs 1:45-56
    • (1994) CNS Drugs , vol.1 , pp. 45-56
    • Mizuno, B.E.1    Mori, H.2    Kondo, T.3
  • 5
    • 0037176885 scopus 로고    scopus 로고
    • Neuroprotection and dopamine agonists
    • Schapira AHV (2002) Neuroprotection and dopamine agonists. Neurology 58:S9-S18
    • (2002) Neurology , vol.58
    • Schapira, A.H.V.1
  • 6
    • 18244423796 scopus 로고    scopus 로고
    • Transient loss of dopamine autoreceptor control in the presence of highly potent dopamine agonists
    • Mao A, Freeman KH, Tallarida RJ (1996) Transient loss of dopamine autoreceptor control in the presence of highly potent dopamine agonists. Life Sci 59:317-324
    • (1996) Life Sci. , vol.59 , pp. 317-324
    • Mao, A.1    Freeman, K.H.2    Tallarida, R.J.3
  • 8
    • 0035936962 scopus 로고    scopus 로고
    • SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
    • Muralikrishnan D, Ebadi M (2001) SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Brain Res 892:241-247
    • (2001) Brain Res. , vol.892 , pp. 241-247
    • Muralikrishnan, D.1    Ebadi, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.